SECsense Logo

Boston Scientific 8-K Report: Key Financial Insights & Debt Instruments Overview

$BSX
Form 8-K
Filed on: 2025-02-26
Source
Boston Scientific 8-K Report: Key Financial Insights & Debt Instruments Overview

Here are the key insights extracted from the provided financial report section:

  1. Entity Information:
  • Name: Boston Scientific Corporation
  • CIK: 0000885725
  • Incorporation: Delaware
  • Address: 300 Boston Scientific Way, Marlborough, MA 01752-1234
  • Phone Number: 508-683-4000
  1. Report Type and Date:
  • Filing Type: 8-K
  • Filing Date: February 21, 2025
  1. Stock Information:
  • Common Stock: Shares have a par value of $0.01 per share.
  • Stock Ticker: BSX (listed on NYSE).
  1. Debt Instruments:
  • Debt Issuance: 0.625% Senior Notes due 2027.
  • Debt Ticker: BSX27 (listed on NYSE).
  1. Reporting Contexts:
  • The report includes multiple contexts for financial reporting, including:
    • Common Stock classification.
    • Senior Notes due 2027 classification.
  1. XBRL Details:
  • The report is structured in XBRL format, indicating compliance with SEC filing requirements and facilitating automated data extraction.

This summary provides a concise overview of essential details relevant to investors, analysts, and stakeholders reviewing the financial status and obligations of Boston Scientific Corporation as of the specified date.